First COVID-19 Vaccines Receiving the US FDA and EMA Emergency Use AuthorizationFocused Review Published on 2021-03-052022-11-01 Journal: Discoveries [Category] COVID-19, [키워드] authorization Commission Contact contagiousness coronavirus COVID-19 COVID-19 associated symptom Critical EMA Emergency Emergency use authorization Europe European Medicines Agency. globe Government incidence increase in individuals Infection limitations Moderna mRNA vaccine mRNA-based vaccines pandemic Pneumonia reported resource responsible restrict Spread Stage the disease the vaccine Treatment triggered US FDA US Food and Drug Administration USA Vaccine Vaccine development virus Wuhan [DOI] 10.15190/d.2021.1 PMC 바로가기 [Article Type] Focused Review
Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 InfectionSARS-CoV-2 감염 이전에 BNT162b2 mRNA COVID-19 백신에 대한 항체 반응Clinical Trial Published on 2021-03-052022-08-13 Journal: Viruses [Category] SARS, 임상, 진단, [키워드] all subject all subjects analyzed Anti-spike anti-spike RBD IgG antibody antibody antibody levels Antibody Response Antibody titers BNT162b2 BNT162b2 mRNA BNT162b2 mRNA COVID-19 vaccine booster both groups control subject COVID-19 COVID-19 vaccine COVID-19 vaccines decrease develop domain effective response expected first dose Frequency healthcare worker IgG antibodies IgG antibody immune memory immune memory persist immune response immunogenicity individual induce infected individuals Infection local pain naïve individuals naïve subject naïve subjects natural infection Neutralizing antibodies neutralizing antibody Neutralizing antibody titer neutralizing antibody titers nine no significant difference not significantly different pre-existing immunity rapid increase RBD reactogenicity response SARS-CoV-2 SARS-COV-2 infection Side effects single dose subjects sustained the antibody response the vaccine titers vaccination Vaccine vaccine dose vaccine doses vaccine-associated side effects [DOI] 10.3390/v13030422 PMC 바로가기 [Article Type] Clinical Trial
Comparative Assessment of Sera from Individuals after S-Gene RNA-Based SARS-CoV-2 Vaccination with Spike-Protein-Based and Nucleocapsid-Based Serological AssaysCommunication Published on 2021-03-032022-10-31 Journal: Diagnostics [Category] COVID-19, [키워드] Anti-spike antibody assessment Breakthrough infection Comparative COVID-19 detectable different time point Effect epitope Euroimmun expected first dose humoral IgA IgG IgM individual natural infection nucleocapsid positive Protein RNA vaccine SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 spike protein second dose serological serological response serology serum sample specificity Spike protein Surveillance the vaccine vaccination vaccination against COVID-19 vaccinee while [DOI] 10.3390/diagnostics11030426 PMC 바로가기 [Article Type] Communication
Acceptance of a COVID-19 Vaccine in Japan during the COVID-19 PandemicArticle Published on 2021-03-032022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] acceptance addition Analysis asked coronavirus disease COVID-19 COVID-19 infection COVID-19 vaccine cross-sectional Effectiveness Epidemiology Factor Factors groups Japan likelihood multiple logistic regression participant proportion PROTECT Protective Psychological public health question Sociodemographic sociodemographic factors the vaccine vaccination Vaccine Vaccine hesitancy women [DOI] 10.3390/vaccines9030210 PMC 바로가기 [Article Type] Article
Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies비활성화된 SARS-CoV-2 백신의 면역원성과 안전성: 전임상 연구Article Published on 2021-03-032022-09-10 Journal: Vaccines [Category] 비임상, [키워드] Antibody titers approved AstraZeneca booster booster dose breath candidate vaccine challenge clinical development clinical trial control group country effective Efficacy Emergency use experimental models guinea pigs hamster hamsters immunogenicity immunological profile inactivated increase in Infection Laboratory mice Moderna morbidity mRNA Neutralizing antibody titer neutralizing antibody titers pandemic performed Phase I PIGS post vaccination pre-clinical study Preclinical preclinical studies RATs Safety safety evaluation SARS-CoV-2 SARS-CoV-2 vaccine shedding Sinopharm subjects tested the vaccine tolerable Vaccine vaccine safety virus [DOI] 10.3390/vaccines9030214 PMC 바로가기 [Article Type] Article
Correlation between polio immunization coverage and overall morbidity and mortality for COVID-19: an epidemiological study소아마비 예방접종 범위와 COVID-19의 전반적인 이환율 및 사망률 간의 상관관계: 역학 연구Research Article Published on 2021-03-022022-10-31 Journal: Environmental science and pollution research inter [Category] COVID-19, SARS, 폴리오, [키워드] Analysis analyzed conducted continuous variable correlated correlation Coverage COVID-19 death determine effort Endemic Epidemiological study estimate Evidence Frequency global health group immunization Kruskal-Wallis H test live-attenuated vaccine morbidity and mortality normally distributed Observatory P -value percentage polio Population positive correlation protective effect R software Repository significantly Spearman rank correlation spread of COVID-19 Standard deviation supplementary material Support the disease the vaccine vaccination Vaccine variables was used were used WHO World Health Organization’ [DOI] 10.1007/s11356-021-12861-6 PMC 바로가기 [Article Type] Research Article
Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaquesArticle Published on 2021-03-022022-10-29 Journal: Nature Communications [Category] COVID-19, SARS, [키워드] Administered affected alveolar epithelium Bronchoalveolar lavage fluid Candidates clearance clinical development clinical trial COVID-19 pandemic days post-infection develop effective vaccine Efficacy exhibited FIVE four group groups Health histopathological IgG immunized immunogenicity immunohistochemistry inactivated Inactivated Vaccines India interstitial pneumonia lung tissue macaque Macrophage nasal swab Neutralizing antibody titer no evidence of overcome pandemic phase Placebo Pneumonia Preclinical research Protective public health rhesus macaque rhesus macaques SARS-CoV-2 SARS-CoV-2 vaccine second dose the placebo group the vaccine three group throat swab Vaccine vaccine candidate Viral antigen viral infection [DOI] 10.1038/s41467-021-21639-w PMC 바로가기 [Article Type] Article
β-glucans: wide-spectrum immune-balancing food-supplement-based enteric (β-WIFE) vaccine adjuvant approach to COVID-19Article Commentary Published on 2021-03-022022-10-31 Journal: Human vaccines & immunotherapeutics [Category] COVID-19, MERS, SARS, [키워드] activating adaptive adjuvant AFO-202 Beta glucan antigenic approach binding biological response modifier Bone marrow clinical trial Conventional COVID-19 COVID-19 pandemic effort Epigenetic immune Immune Enhancement Immunity induce Influenza Innate immunity lymphoid organs Modification mucosal Mutation pathogen pathogen-associated molecular patterns receptor reported Stage the vaccine trained immunity Treatment Vaccine vaccine adjuvant virus [DOI] 10.1080/21645515.2021.1880210 PMC 바로가기 [Article Type] Article Commentary
Acceptability of a COVID-19 Vaccine Among Healthcare Workers in the Kingdom of Saudi ArabiaMedicine Published on 2021-03-012022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] acceptability affecting alleviate being calculated conducted country COVID-19 COVID-19 vaccination COVID-19 vaccine cross-sectional survey determine Factor Frequency healthcare worker Healthcare workers Hesitancy high risk identify Infection Intention Kingdom logistic regression model male multivariable Probability questionnaire Regression analyses Risk perception Saudi Arabia Sociodemographic characteristics Study participants the vaccine used data vaccinate Vaccine variables was used worker [DOI] 10.3389/fmed.2021.644300 PMC 바로가기 [Article Type] Medicine
COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countriesVaccine Confidence Published on 2021-03-012022-10-31 Journal: European Journal of Epidemiology [Category] COVID-19, MERS, [키워드] acceptance Administered children Compliance country COVID-19 COVID-19 vaccination COVID-19 vaccine distribution Effective vaccines Effectiveness Efficacy estimate highest India indicated Intention Latin lowest morbidity and mortality mother populations predictor predictors Pregnancy pregnant pregnant women public health receive reducing response Russia supplementary material the United State the vaccine vaccinate vaccination Vaccine Vaccine acceptance vaccine administration Vaccine confidence Vaccines were assessed women [DOI] 10.1007/s10654-021-00728-6 PMC 바로가기 [Article Type] Vaccine Confidence